MSc Graduate Student Position: Development of next-generation BCG vaccines for human tuberculosis
Start Date: January 2018
Program of Study: Master’s degree (MSc) in the Vaccinology & Immunotherapeutics Program of the School of Public Health, University of Saskatchewan, with the possibility of continuing towards a Doctorate degree (PhD). For info. visit: https://www.usask.ca/sph/index.php
We are seeking to recruit a graduate student to develop novel bacillus Calmette-Guerin (BCG) vaccines against human TB. The candidate will become competent in mycobacterial genetics, biochemistry and vaccine development by the end of their training.
Financial Support: The graduate trainee is guaranteed a stipend during their training. However, he or she will be expected to apply for internal and/or external scholarships in the future. For info. visit: https://www.usask.ca/sph/index.php
Research Advisor: Jeffrey Chen, PhD
Have or expecting to obtain a BSc degree either in Genetics, Molecular Biology, Immunology or Microbiology. Documented working knowledge of molecular biology and immunological techniques would be an asset. The trainee must be highly motivated and proficient in English (spoken and written). The graduate trainee will be working under high-security biosafety level-3 conditions, as such he or she must undergo and pass a criminal and security background check.
How to Apply:
Interested candidates should submit electronically, one single application document (pdf file) that includes 1) a letter of motivation, 2) a complete curriculum vitae (CV), 3) a copy of undergraduate transcripts, and 4) contact information for three individuals each willing to provide a reference for the candidate, to email@example.com
VIDO-InterVac and the University of Saskatchewan is strongly committed to a diverse and inclusive workplace. As such, applications from those who will contribute to the diversity of our community are welcome and all qualified candidates are encouraged to apply. However, Canadian citizens and permanent residents will be given priority.
Only candidates selected for interviews will be contacted